Live Breaking News & Updates on Allogene Therapeutics Company Profile

Stay updated with breaking news from Allogene therapeutics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Insider Selling: Allogene Therapeutics, Inc. (NASDAQ:ALLO) Director Sells 11,200 Shares of Stock

Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) Director Franz B. Humer sold 11,200 shares of the company’s stock in a transaction that occurred on Thursday, May 30th. The stock was sold at an average price of $2.34, for a total value of $26,208.00. Following the completion of the sale, the director now owns 255,253 […] ....

Canada , Franzb-humer , Piper-sandler , Canada-life-assurance , Pricet-rowe-associates-inc , Allogene-therapeutics-company-profile , Nasdaq , Allogene-therapeutics-inc , Susquehanna-fundamental-investments , Jpmorgan-chase-co , Securities-exchange-commission , Headlands-technologies

Q2 2024 EPS Estimates for Allogene Therapeutics, Inc. Lowered by William Blair (NASDAQ:ALLO)

Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) – Research analysts at William Blair decreased their Q2 2024 EPS estimates for shares of Allogene Therapeutics in a research report issued on Tuesday, May 14th. William Blair analyst S. Corwin now expects that the company will post earnings per share of ($0.39) for the quarter, down from […] ....

Canada , Arizona , United-states , Stifel-nicolaus , William-blair , Allogene-therapeutics-company-profile , Victory-capital-management-inc , Principal-financial-group-inc , Harbor-capital-advisors-inc , Vontobel-holding-ltd , Royal-bank , Allogene-therapeutics-inc

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Given Consensus Recommendation of "Moderate Buy" by Analysts

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Given Consensus Recommendation of "Moderate Buy" by Analysts
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Canada , China , Mirae-asset-global-investments-co , Susquehanna-fundamental-investments , Headlands-technologies , Allogene-therapeutics-inc , Nasdaq , Allogene-therapeutics-company-profile , Royal-bank , China-universal-asset-management-co , Bourgeon-capital-management

Allogene Therapeutics (ALLO) Set to Announce Quarterly Earnings on Monday

Allogene Therapeutics (ALLO) Set to Announce Quarterly Earnings on Monday
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Canada , Allogene-therapeutics-inc , Allogene-therapeutics-company-profile , Jpmorgan-chase-co , Royal-bank , Nasdaq , Allogene-therapeutics , Get-free-report , Therapeutics-stock-down , Allogene-therapeutics-daily ,

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Receives $12.72 Average Target Price from Brokerages

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Receives $12.72 Average Target Price from Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada , Alps , Switzerland-general , Switzerland , Swiss , Citigroup-inc , Allogene-therapeutics-company-profile , Nasdaq , Alps-advisors-inc , Allogene-therapeutics-inc , Jpmorgan-chase-co